跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,322 条关于
“Intrahepatic Cholangiocarcinoma”
全部
1,322
临床试验
1,155
药物
10
机构
0
资讯
157
6个月前
Chinese Study Shows Neoadjuvant Therapy Nearly Doubles Disease-Free Survival in Intrahepatic Cholangiocarcinoma
3年前
Toripalimab, Lenvatinib, and GEMOX Combination Shows Promise in Advanced Intrahepatic Cholangiocarcinoma
去年
HAIC Plus Lenvatinib and PD-1 Inhibitors Improve Outcomes in Advanced Intrahepatic Cholangiocarcinoma
去年
FDA Approves Zanidatamab (Ziihera) for HER2-Positive Biliary Tract Cancer
去年
HUTCHMED Completes Enrollment for Phase II Registration Trial of Fanregratinib in FGFR2-Fusion Cholangiocarcinoma
去年
Real-World Data Confirm Ivosidenib Efficacy in IDH1-Mutated Cholangiocarcinoma
去年
Eisai Seeks Japanese Approval for Novel FGFR Inhibitor Tasurgratinib in Biliary Tract Cancer
去年
PLT012 Receives FDA Orphan Drug Designation for Liver and Bile Duct Cancers
去年
FDA Approves Zanidatamab (Ziihera) for HER2-Positive Biliary Tract Cancer
11年前
Tyra Biosciences Advances FGFR Inhibitor Pipeline with Multiple Clinical Trials
第 1 页，共 16 页
上一页
下一页
